Klin Farmakol Farm. 2020;34(3):116-121 | DOI: 10.36290/far.2020.021

Drug‑related problems in theory and practice in the Czech Republic

Josef Malý
Katedra sociální a klinické farmacie, Farmaceutická fakulta UK v Hradci Králové

Patient safety issues are still a current problem, both for its impact on public health and for high economic burden. The aim of this paper is to demonstrate and discuss aspects associated with the safety culture in the provision of pharmacotherapy with emphasis on drug-related problems (DRP) and methods of their identification in the Czech Republic. DRPs are a link between healthcare professionals and medication review is a way by which pharmacists can manage DRPs at various levels.

Keywords: drug‑related problem, medication review, clinical pharmacy, pharmaceutical care.

Published: November 6, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malý J. Drug‑related problems in theory and practice in the Czech Republic. Klin Farmakol Farm. 2020;34(3):116-121. doi: 10.36290/far.2020.021.
Download citation

References

  1. International Pharmaceutical Federation. Joint FIP/WHO Guidelines on Good Pharmacy Practice - Standards for Quality Services [Internet]. [Hague (The Netherlands)]: fip.org; [cited 2018 Dec 29]. Available from: http://www.fip.org/www/uploads/database_file.php?id=331 & table_id.
  2. Edwards LD, Fletcher AJ, Fox AW, Stonier PD. Principles and practice of pharmaceutical medicine. 2nd ed. Chichester, West Sussex: John Wiley and Sons Ltd.; 2007; 761:p. ISBN 978-0-470-09313-9. Go to original source...
  3. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999. ISBN 0-309-06837-1.
  4. World Health Organization. 10 facts on patient safety [Internet]. [Geneva (Switzerland)]: c2018 [cited 2018 Dec 28]. Available from: https://www.who.int/features/factfiles/patient_safety/en/.
  5. Cohen MR. Medication Errors. 2nd ed. Washington, DC: The American Pharmacists Association; 2007; 680: p. ISBN 978-1-58212-092-8.
  6. Expert Group on Safe Medication Practices. Creation of a better medication safety culture in Europe: Building up safe medication practices [Internet]. [Place unknown]: optimiz‑sih‑circ‑med.fr; c2006 [cited 2018 Dec 30]. Available from: http://optimiz‑sih‑circ‑med.fr/Documents/Council_of_Europe_Medication_Safety_Report_19-03-2007.pdf.
  7. Burgess LH, Cohen MR, Denham CR. A new leadership role for pharmacists: a prescription for change. J Patient Saf. 2010; 6(1): 31-37. Go to original source... Go to PubMed...
  8. Zákon č. 372/2011 Sb., o zdravotních službách a podmínkách jejich poskytování [Internet]. [Place unknown]: zakonyprolidi.cz; c2018 [cited 2018 Dec 29]. Available from: https://www.zakonyprolidi.cz/cs/2011-372/zneni-20180701.
  9. Malý J. Analýza možnosti aplikovat klinickou farmacii do farmaceutické péče. [Disertační práce]. Hradec Králové: Univerzita Karlova, Farmaceutická fakulta v Hradci Králové 2013; 151 p.
  10. Vlček J, Fialová D, Malý J, Pávek P, Halačová M, Doseděl M, Kotolová H, Horská K. Koncepce oboru klinická farmacie I., vzdělávací část. Ceska Slov Farm. 2016; 65(Suppl): 1-20.
  11. Krähenbühl‑Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug‑related problems in hospitals: a review of the recent literature. Drug Saf. 2007; 30(5): 379-407. Go to original source...
  12. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997; 22-29; 277(4): 307-311. Go to original source...
  13. Úřední věstník Evropské unie, Doporučení Rady ze dne 9. 6. 2009 o bezpečnosti pacientů včetně prevence a kontroly infekcí spojených se zdravotní péčí (2009/C 151/01) [Internet]. [Place unknown]: eur‑lex.europa.eu; c2018 [cited 2018 Dec 29]. Available from: https://eur‑lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0001:0006:CS:PDF.
  14. Vitillo JA, Lesar TS Preventing medication prescribing errors. DICP. 1991;25 (12): 1388-1394. Go to original source... Go to PubMed...
  15. Bondesson A, Eriksson T, Kragh A, Holmdahl L, Midlöv P, Höglund P. In‑hospital medication reviews reduce unidentified drug‑related problems. Eur J Clin Pharmacol. 2013; 69(3): 647-655. Go to original source... Go to PubMed...
  16. Miguel A, Azevedo LF, Araújo M, Pereira AC. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta‑analysis. Pharmacoepidemiol Drug Saf. 2012; 21(11): 1139-1154. Go to original source... Go to PubMed...
  17. European Medicines Agency. Medication Errors [Internet]. [London (UK)]: ema.europa.eu; c2018 [cited 2018 Dec 27]. Available from: https://www.ema.europa.eu/en/human‑regulatory/post‑authorisation/pharmacovigilance/medication‑errors.
  18. National Coordinating Council for Medication Error Reporting and Prevention. About Medication Errors [Internet]. [place unknown]: www.nccmerp.org; c2019 [cited 2019 Jan 2]. Available from: www.nccmerp.org/about‑medication‑errors
  19. da Costa FA, van Mil, JWF, Alvarez‑Risco A. The pharmacist guide to implementing pharmaceutical care. 1st ed. Cham, Switzerland: Springer International Publishing; 2019, 506 p. ISBN 978-3-319-92575-2. Go to original source...
  20. Aronson J. Medication reconciliation. BMJ. 2017 Jan 13;356:i5336. Go to original source... Go to PubMed...
  21. Mekonnen AB, McLachlan AJ, Brien JA. Pharmacy‑led medication reconciliation programmes at hospital transitions: a systematic review and meta‑analysis. J Clin Pharm Ther. 2016; 41(2): 128-144. Go to original source... Go to PubMed...
  22. Griese‑Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, Kos M. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018; 40(5): 1199-1208. Go to original source... Go to PubMed...
  23. Malý J. Řešení lékových problémů a nežádoucí účinky léčiv. In: Seberová D., editor. Doporučené postupy České lékárnické komory pro konzultační činnost v lékárnách 2010. Olomouc: Solen, 2010. pp. 41-54. ISBN 978-80-87327-48-7.
  24. Malý J, Ládová K, Doseděl M, Vlček J. Hodnocení role farmaceuta při managementu drug‑related problems - zkušenosti z revize zdravotnické dokumentace. Farm Obz. 2013; 82(8): 219-224.
  25. Močárková Z. Analýza lékových problémů identifikovaných farmaceutem při dispenzační činnosti a vliv intervence farmaceuta směrem k předepisujícím lékařům. [Rigorózní práce]. Hradec Králové: Farmaceutická fakulta UK v Hradci Králové; 2013. 147 p.
  26. Dobrucká K, Malý J, Vlček J. Analýza role farmaceuta při poskytování konzultací pacientům s rizikem nadváhy nebo obezity v lékárně. Klin Farmakol Farm. 2012; 26(3): 117-120.
  27. Gregor S. Analýza péče o pacienty s rizikem arteriální hypertenze v lékárně I. [Diplomová práce]. Hradec Králové: Farmaceutická fakulta UK v Hradci Králové; 2013. 100 p.
  28. Kotlanová L. Analýza péče o pacienty s rizikem arteriální hypertenze v lékárně IV. [Diplomová práce]. Hradec Králové: Farmaceutická fakulta UK v Hradci Králové; 2015. 96 p.
  29. Dosedel M, Maly J, Marecek A, Solinova J, Novosad A, Zimcikova E, Ladova K. Management of drug related problems in pharmacies in the Czech Republic. Int J Clin Pharm. 2018; 40(1): 229. Abstrakt.
  30. Maly J, Dosedel M, Vosatka J, Mala‑Ladova K, Kubena AA, Brabcova I, Hajduchova H, Bartlova S, Tothova V, Vlcek J. Pharmacotherapy as major risk factor of falls - analysis of 12 months experience in hospitals in South Bohemia. J Appl Biomed. 2019; 17(1): 53-60. Go to original source... Go to PubMed...
  31. Maly J, Dosedel M, Kubena AA, Mala‑Ladova K, Vosatka J, Brabcova I, Hajduchova H, Bartlova S, Tothova V, Vlcek J. Analysis of the fall‑related risk of pharmacotherapy in Czech hospitals: A case control study. J Eval Clin Pract. 2020; 26(3): 973-982. Go to original source... Go to PubMed...
  32. Bjeldbak‑Olesen M, Danielsen AG, Tomsen DV, Jakobsen TJ. Medication reconciliation is a prerequisite for obtaining a valid medication review. Dan Med J. 2013; 60(4): A4605. Go to PubMed...
  33. Malý J. Možnosti rozvoje kultury bezpečí ve farmakoterapii. [Habilitační práce]. Hradec Králové: Univerzita Karlova, Farmaceutická fakulta v Hradci Králové; 2019, 107 p.
  34. Otero MJ, Schmitt E. Clarifying terminology for adverse drug events. Ann Intern Med. 2005 Jan 4;142(1):77; author reply 77-78. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.